Smith, Edward M., Zhang, Y., Baye, T. M., Gawrieh, S., Cole, R., Blangero, J., Carless, Melanie A., Curran, Joanne E., Dyer, T. D., Abraham, L. J., Moses, E. K. (Eric Keith), Kissebah, Ahmed, Martin, L. J. (Lisa J.) and Olivier, M. (Michael). (2010) INSIG1 influences obesity-related hypertriglyceridemia in humans. Journal of Lipid Research, Vol.51 . pp. 701-708. ISSN 0022-2275

PDF WRAP_Smith_bs-031110-smith_et_al_2010jlr.pdf - Draft Version - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (591Kb)

Abstract

In our analysis of a quantitative trait locus (QTL) for plasma triglyceride (TG) levels [logarithm of odds (LOD) = 3.7] on human chromosome 7q36, we examined 29 single nucleotide polymorphisms (SNPs) across INSIG1, a biological candidate gene in the region. Insulin-induced genes (INSIGs) are feedback mediators of cholesterol and fatty acid synthesis in animals, but their role in human lipid regulation is unclear. In our cohort, the INSIG1 promoter SNP rs2721 was associated with TG levels (P = 2 × 10−3 in 1,560 individuals of the original linkage cohort, P = 8 × 10−4 in 920 unrelated individuals of the replication cohort, combined P = 9.9 × 10−6). Individuals homozygous for the T allele had 9% higher TG levels and 2-fold lower expression of INSIG1 in surgical liver biopsy samples when compared with individuals homozygous for the G allele. Also, the T allele showed additional binding of nuclear proteins from HepG2 liver cells in gel shift assays. Finally, the variant rs7566605 in INSIG2, the only homolog of INSIG1, enhances the effect of rs2721 (P = 0.00117). The variant rs2721 alone explains 5.4% of the observed linkage in our cohort, suggesting that additional, yet-undiscovered genes and sequence variants in the QTL interval also contribute to alterations in TG levels in humans.

Item Type:	Journal Article
Subjects:	Q Science > QH Natural history > QH426 Genetics R Medicine > RC Internal medicine
Divisions:	Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH):	Hypertriglyceridemia -- Genetic aspects, Triglycerides, Gene expression
Journal or Publication Title:	Journal of Lipid Research
Publisher:	American Society for Biochemistry and Molecular Biology, Inc.
ISSN:	0022-2275
Date:	April 2010
Volume:	Vol.51
Page Range:	pp. 701-708
Identification Number:	10.1194/jlr.M001404
Status:	Peer Reviewed
Access rights to Published version:	Restricted or Subscription Access
Funder:	National Institutes of Health (U.S.) (NIH)
Grant number:	HL74168 (NIH)
References:	1. Forrester, J. S. 2001. Triglycerides: risk factor or fellow traveler? Curr Opin Cardiol. 16: 261-264. 2. Malloy, M. J. and J. P. Kane. 2001. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med. 47: 111-136. 3. Connelly, P. W., A. Petrasovits, S. Stachenko, D. R. MacLean, J. A. Little, and A. Chockalingam. 1999. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol. 15: 428-433. 4. Tai, E. S., S. C. Emmanuel, S. K. Chew, B. Y. Tan, and C. E. Tan. 1999. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes. 48: 1088-1092. 5. Austin, M. A., M. C. King, R. D. Bawol, S. B. Hulley, and G. D. Friedman. 1987. Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol. 125: 308-318. 6. Heller, D.A., U. de Faire, N. L. Pedersen, G. Dahlen, and G. E. McClearn, 1993. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 328: 1150-1156. 7. Perusse, L., T. Rice, J. P. Despres, J. Bergeron, M. A. Province, J. Gagnon, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, et al. 1997. Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 17: 3263-3269. 8. Kissebah, A. H., S. Alfarsi, and P. W. Adams. 1981. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 30: 856-868. 9. Kissebah, A. H., G. E. Sonnenberg, J. Myklebust, M. Goldstein, K. Broman, R. G. James, J. A. Marks, G. R. Krakower, H. J. Jacob, J. Weber, et al. 2000. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 97: 14478-14483. 10. Sonnenberg, G. E., G. R. Krakower, L. J. Martin, M. Olivier, A. E. Kwitek, A. G. Comuzzie, J. Blangero, and A. H. Kissebah. 2004 Genetic determinants of obesity-related lipid traits. J Lipid Res. 45: 610-615. 11. Li, W. D., C. Dong, D. Li, C. Garrigan, and R. A. Price. 2005. A genome scan for serum triglyceride in obese nuclear families. J Lipid Res. 46: 432-438. 12. Duggirala, R., J. Blangero, L. Almasy, T. D. Dyer, K. L. Williams, R. J. Leach, P. O'Connell, and M. P. Stern. 2000. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet. 66: 1237-1245. 13. Horne, B. D., A. Malhotra, and N. J. Camp. 2003. Comparison of linkage analysis methods for genome-wide scanning of extended pedigrees, with application to the TG/HDL-C ratio in the Framingham Heart Study. BMC Genet. 4 Suppl 1, S93. 14. Lin, J. P. 2003. Genome-wide scan on plasma triglyceride and high density lipoprotein cholesterol levels, accounting for the effects of correlated quantitative phenotypes. BMC Genet. 4 Suppl 1, S47. 15. Shearman, A. M., J. M. Ordovas, L. A. Cupples, E. J. Schaefer, M. D. Harmon, Y. Shao, J. D. Keen, A. L. DeStefano, O. Joost, P. W. Wilson, et al. 2000. Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet. 9: 1315-1320. 16. Diamond, R. H., K. Du, V. M. Lee, K. L. Mohn, B. A. Haber, D. S. Tewari, and R. Taub. 1993. Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem. 268: 15185-15192. 17. Peng, Y., E. J. Schwarz, M. A. Lazar, A. Genin, N. B. Spinner, and R. Taub. 1997. Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene. Genomics. 43: 278-284. 18. Yang, T., P. J. Espenshade, M. E. Wright, D. Yabe, Y. Gong, R. Aebersold, J. L. Goldstein, and M. S. Brown. 2002. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 110: 489-500. 19. Radhakrishnan, A., Y. Ikeda, H. J. Kwon, M. S. Brown, and J. L. Goldstein. 2007. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A. 104: 6511-6518. 20. Brown, M. S. and J. L. Goldstein. 1999. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A. 96: 11041-11048. 21. Horton, J. D., I. Shimomura, S. Ikemoto, Y. Bashmakov, and R. E. Hammer. 2003. Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem. 278: 36652-36660. 22. Horton, J. D., J. L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 109: 1125-1131. 23. Goldstein, J. L., R. A. DeBose-Boyd, and M. S. Brown. 2006. Protein sensors for membrane sterols. Cell. 124: 35-46. 24. DeBose-Boyd, R. A. 2008. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 18: 609-621 25. Takaishi, K., L. Duplomb, M. Y. Wang, J. Li, and R. H. Unger. 2004. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci U S A. 101: 7106-7111. 26. Engelking, L. J., G. Liang, R. E. Hammer, K. Takaishi, H. Kuriyama, B. M. Evers, W. P. Li, J. D. Horton, J. L. Goldstein, and M. S. Brown. 2005. Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. J Clin Invest. 115: 2489-2498. 27. Olivier, M. 2005. The Invader assay for SNP genotyping. Mutat Res. 573: 103-110. 28. Olivier, M., L. M. Chuang, M. S. Chang, Y. T. Chen, D. Pei, K. Ranade, A. de Witte, J. Allen, N. Tran, D. Curb, et al. 2002. High-throughput genotyping of single nucleotide polymorphisms using new biplex invader technology. Nucleic Acids Res. 30: e53. 29. Pennacchio, L. A., M. Olivier, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294: 169-173. 30. Pennacchio, L. A., M. Olivier, J. A. Hubacek, R. M. Krauss, E. M. Rubin, and J. C. Cohen. 2002. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 11: 3031-3038. 31. Nickerson, D. A., V. O. Tobe, and S. L. Taylor. 1997. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25: 2745-2751. 32. Marth, G. T., I. Korf, M. D. Yandell, R. T. Yeh, Z. Gu, H. Zakeri, N. O. Stitziel, L. Hillier, P. Y. Kwok, and W. R. Gish. 1999. A general approach to single-nucleotide polymorphism discovery. Nature Genetics. 23: 452-456. 33. Goring, H. H., J. E. Curran, M. P. Johnson, T. D. Dyer, J. Charlesworth, S. A. Cole, J. B. Jowett, L. J. Abraham, D. L. Rainwater, A. G. Comuzzie, et al. 2007. Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes. Nat Genet. 39: 1208-1216. 34. Li, Y. C., J. Ross, J. A. Scheppler, and B. R. Jr. Franza. 1991. An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators. Mol Cell Biol. 11: 1883-1893. 35. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263-265. 36. de Bakker, P. I., R. Yelensky, I. Pe'er, S. B. Gabriel, M. J. Daly, and D. Altshuler. 2005. Efficiency and power in genetic association studies. Nat Genet. 37: 1217-1223. 37. Falconer, D. S. 1989. Introduction to Quantitative Genetics. 3 ed. Longman Scientific and Technical, New York, NY. 38. Almasy, L. and J. Blangero. 1998. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet. 62: 1198-1211. 39. Whitlock, M. C. 2005. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol. 18: 1368-1373. 40. Cox, N. J., M. Frigge, D. L. Nicolae, P. Concannon, C. L. Hanis, G. I. Bell, and A. Kong. 1999. Loci on chromosome 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nature Genetics. 21: 213-215. 41. Herbert, A., N. P. Gerry, M. B. McQueen, I. M. Heid, A. Pfeufer, T. Illig, H. E. Wichmann, T. Meitinger, D. Hunter, F. B. Hu, et al. 2006. A common genetic variant is associated with adult and childhood obesity. Science. 312: 279-283. 42. Hotta, K., M. Nakamura, Y. Nakata, T. Matsuo, S. Kamohara, K. Kotani, R. Komatsu, N. Itoh, I. Mineo, J. Wada, et al. 2008. INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese. J Hum Genet. 53: 857-862. 43. Oki, K., K. Yamane, N. Kamei, T. Asao, T. Awaya, and N. Kohno. 2008. The single nucleotide polymorphism upstream of insulin-induced gene 2 ( INSIG2) is associated with the prevalence of hypercholesterolaemia, but not with obesity, in Japanese American women. Br J Nutr. 1-6. 44. Kim, S. K., L. Selleri, J. S. Lee, A. Y. Zhang, X. Gu, Y. Jacobs, and M. L. Cleary. 2002. Pbx1 inactivation disrupts pancreas development and in Ipf1-deficient mice promotes diabetes mellitus. Nat Genet. 30: 430-435. 45. Miller, M., C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, E. Braunwald. 2008. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 Trial. J Am Col Cardiol. 51:724-730. 46. Kitsios, G.D. and E. Zintzaras. 2009. Genomic Convergence of Genome-wideInvestigations for Complex Traits. Ann Hum Genet.2009 Jul 9. [Epub ahead of print].
URI:	http://wrap.warwick.ac.uk/id/eprint/3618

Request changes to a record

Actions (login required)

View Item